Beginning to recover
Profit doubled since 2020
Company trading on a 28.4% premium
Unilever has faced a tumultuous few weeks as news of its failed £50bn bid to buy GlaxoSmithKline’s consumer health unit came to light along with job cuts, scathing remarks from star fund managers and an activist investor taking a position.
Tech giant 'impossible to avoid'
AUM and AUA up to £68.2bn
Group shows resilience